Advanced Search

per page
  Report Title Date Provider Type Pgs Price

Cubist Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

16 Jan 2015 Reuters Investment Profile 12 $20.00

Cubist Pharmaceuticals

20 Jan 2015 S&P Capital IQ Factual Report 13 $150.00

"The Economy Matters" Report for CBST: the economy's impact on CBST's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

19 Jan 2015 MacroRisk Analytics/EconomicInvestor 8 $25.00

Validea Guru Analysis Report for CBST. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.

Validea's Guru Stock Report uses an interpretation of the published stock-picking strategies developed by 10 investing legend...

16 Jan 2015 Validea 0 $12.00

ValuEngine Industry Report for Medical-drugs

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

16 Jan 2015 ValuEngine, Inc. 10 $49.00


16 Jan 2015 Ford Investor Services, Inc. 1 $12.00

Cubist Pharmaceuticals, Inc.

Cubist Pharmaceuticals (Cubist or 'the company') is a biopharmaceutical company focused on the research, development and com...

13 Jan 2015 MarketLine (a Datamonitor Company) 52 $175.00

ValuEngine Rating and Forecast Report for CBST

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

12 Jan 2015 ValuEngine, Inc. 11 $25.00 Ratings Stock Report For: CUBIST PHARMACEUTICALS INC (CBST)

11 Jan 2015 Ratings 5 $10.00

Will Cubist Pharmaceuticals Inc Deliver Long-Term Returns?

09 Jan 2015 Sadif Analytics Prime 12 $25.00